Estimated Diabetes In Japan Grows To One Per Every 5.6 Adults
This article was originally published in PharmAsia News
According to a National Health and Diet Survey of 2006 conducted by Japan's Ministry of Heath, Labor and Welfare, released on April 30, the total number of diabetes patients and candidates is estimated to be 18.7 million, an increase of 15.4 percent or 2.5 million since 2002. MHLW sites a rapidly aging population, lack of exercise and high calorie diets as reasons. The estimate is based on a survey conducted in 3,600 families and utilizing blood samples of 4,296 adults. (Click here for more - Japanese language
You may also be interested in...
TOKYO - AstraZeneca K.K., a fully owned Japanese subsidiary of AstraZeneca, has announced plans to market type 2 diabetes treatment dapagliflozin jointly with Bristol-Meyers Squibb in Japan, a company spokesman said
Takeda launches blockbuster gastrointestinal drug vedolizumab in India, stepping up the tempo on the back of the local base provided by its acquisition of Shire. More expansion in the country appears to be in store for the Japanese firm.
The US FDA’s Circulatory System Devices advisory panel will meet on 27 October to discuss the review of the premarket approval application of Neovasc’s Reducer device, which is intended to treat angina. See what Neovasc’s CEO Fred Colen said about it here.